Gelesis Inc — Form D
Gelesis Inc of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-06-09. The offering totals $2.6M, of which $2.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-06-09
- Form: D
- Accession: 0000908662-11-000156
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.6M
- Amount sold: $2.6M
- Investors: 11
- Date of first sale: 2011-05-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-161051
Issuer
- Name: Gelesis Inc
- CIK: 0001385374
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 501 BOYLSTON STREET, SUITE 6102, Boston, MA, 02116
- Phone: 617-456-4718
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Mendy Axelrad | Director | Boston, MA |
| Eric Elenko | Director | Boston, MA |
| Rishi Gupta | Director | New York, NY |
| Elon Boms | Director | New Haven, CT |
| John LaMattina | Director | Cambridge, MA |
| Elliot Maltz | Executive Officer | Germantown, MD |
| Yishai Zohar | Director | BOSTON, MA |
| Yishai Zohar | Executive Officer | BOSTON, MA |
| Robert Forrester | Director | CAMBRIDGE, MA |
| Meghan Fitzgerald | Director | Northampton, MA |
Other filings by this issuer (2)
More